Evidence map›Paper›PMID 40604219›Full record

ArticleScientific reports2025

Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections.

Ingrid Nayara Marcelino Santos, Felipe Alberto-Lei, Fernanda Fernandes Santos, Mariana Felix Cerqueira Balera, Mariana Neri Kurihara, Carolina Coelho Cunha, Laís Sales Seriacopi, Thomas Stravinskas Durigon, Fernando Baldy Reis, Ana Karolina Antunes Eisen and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Search for Potentially VirulentInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Beneficial perspective onFrontiers in immunology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ingrid Nayara Marcelino Santos *Laboratório Especial de Microbiologia Clínica (LEMC), Departamento de Medicina, Disciplina de Infectologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Felipe Alberto-Lei *Laboratório Especial de Microbiologia Clínica (LEMC), Departamento de Medicina, Disciplina de Infectologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Fernanda Fernandes SantosLaboratório Especial de Microbiologia Clínica (LEMC), Departamento de Medicina, Disciplina de Infectologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Mariana Felix Cerqueira BaleraLaboratório Especial de Microbiologia Clínica (LEMC), Departamento de Medicina, Disciplina de Infectologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Mariana Neri KuriharaLaboratório Especial de Microbiologia Clínica (LEMC), Departamento de Medicina, Disciplina de Infectologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Carolina Coelho CunhaGrupo de Infecção Musculoesquelética, Departamento de Ortopedia e Traumatologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Laís Sales SeriacopiGrupo de Infecção Musculoesquelética, Departamento de Ortopedia e Traumatologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Thomas Stravinskas DurigonGrupo de Infecção Musculoesquelética, Departamento de Ortopedia e Traumatologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Fernando Baldy ReisGrupo de Infecção Musculoesquelética, Departamento de Ortopedia e Traumatologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil.
Ana Karolina Antunes EisenLaboratório de Virologia Clínica e Molecular, Departamento de Microbiologia, Universidade de São Paulo (USP), São Paulo, Brazil.
Giovana Santos CaleiroLaboratório de Virologia Clínica e Molecular, Departamento de Microbiologia, Universidade de São Paulo (USP), São Paulo, Brazil.
Jansen de AraújoLaboratório de Virologia Clínica e Molecular, Departamento de Microbiologia, Universidade de São Paulo (USP), São Paulo, Brazil.
Edison Luiz DurigonLaboratório de Virologia Clínica e Molecular, Departamento de Microbiologia, Universidade de São Paulo (USP), São Paulo, Brazil.
Giselle Burlamaqui KlautauDisciplina de Infectologia, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.
Mauro José SallesLaboratório Especial de Microbiologia Clínica (LEMC), Departamento de Medicina, Disciplina de Infectologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, 04025-010, Brazil. salles.infecto@gmail.com.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 306760/2021-5Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.817948/2023-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/20959-7
6 · The paper itself

Abstract

Staphylococcus epidermidis is an opportunistic commensal cutaneous biofilm-producing agent frequently causing musculoskeletal infections (MSI) with/without implants. This study was design to evaluate phenotypic and genomic relatedness between commensal skin and MSI S. epidermidis isolates and to assess patient-related and microbial markers in the outcome of patients after one-year follow-up. Demographics, clinical data and monomicrobial S. epidermidis isolates of MSI patients (n = 31) and healthy individuals (n = 15) were analyzed. Phenotypic profile was assessed by susceptibility tests by broth microdilution and biofilm formation. Phylogenetic relationships, resistome characterization, and virulome analysis were carried out by complete genome sequencing (n = 46). Overall, MSI-derived isolates were significantly more strong/moderate biofilm producers and depicted higher rates of resistance to methicillin (MRSE), ciprofloxacin, gentamicin and rifampicin. Demographics and clinical characteristics did not significantly affect MSI patients' outcomes. In the whole-genomic sequencing (WGS) phylogeny, most MSI-derived isolates were grouped into the pathogenic-associated clonal complex CC2, and significantly higher prevalence of mecA gene and pathogenic marker IS256. Following multivariate analysis, MSI-derived isolates carrying transposable element IS256 are more likely to develop a persistent infection (odds ratio [OR], 8.00, [95% confidence interval (CI), 1.06 to 60.31], P = 0.044), while weaker biofilm producer were protectors (OR, 0.070, 95%CI, 0.005-0.979, P = 0.048), reducing the chance of recurrence by 93% (1-0.070). The logistic regression model's performance was evaluated by Nagelkerke's R, which resulted in 47.21%. In conclusion, S. epidermidis isolates producing MSI were phenotypically and genetically distinct from commensals, proven the association between independent genetic traits and patient's outcome.

Indexed as

Drug Resistance, BacterialMusculoskeletal DiseasesStaphylococcal InfectionsStaphylococcus epidermidisVirulence FactorsAdultAgedAnti-Bacterial AgentsBiofilmsFemaleGenome, BacterialGenomicsHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsVirulence FactorsBiofilm productionCoagulase-negative StaphylococcimecA geneMobile genetic elementPhylogenyStaphylococcus epidermidisTreatment recurrenceWhole-genomic sequencing

Identifiers

PMID40604219
PMCPMC12223301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.